Nefopam enhances the protective activity of antiepileptics against maximal electroshock-induced convulsions in mice.
Journal Title: Pharmacological Reports - Year 2011, Vol 63, Issue 3
Abstract
Nefopam is a centrally acting non-opioid analgesic with a mechanism of action that is not completely understood. Adverse effects associated with the therapeutic use and overdose of nefopam are mainly associated with the central nervous system, such as hallucinations, cerebral edema and convulsions. The aim of this study was to assess the effect of nefopam on the electrical threshold and its influence on the protective activity of antiepileptic drugs in the maximal electroshock test in mice. A 5 mg/kg dose of nefopam significantly elevated the electric seizure threshold, while a dose of 1 mg/kg failed to protect mice against electroconvulsion. At a subthreshold dose of 1 mg/kg, nefopam significantly enhanced the anticonvulsant activity of valproate against electroconvulsions. The protective activity of phenobarbital and phenytoin was significantly enhanced by co-administration of nefopam at the 5 mg/kg dose, but this same dose of nefopam failed to affect the protective activity of carbamazepine. In conclusion, nefopam exerts an anticonvulsive effect when given alone and significantly enhances the protective activity of certain antiepileptic agents against electroconvulsions induced in mice.
Authors and Affiliations
Mirosław Czuczwar, Katarzyna Czuczwar, Jacek Cięszczyk, Tomasz Saran, Jarogniew Luszczki, Waldemar Turski
Keywords
Related Articles
- EP ID EP119225
- DOI -
- Views 64
- Downloads 0
Stiripentol. A novel antiepileptic drug.
Epilepsy is one of the most widespread pathologies of human brain, affecting approximately 1% of world population. Despite the development of new methods of seizure control, chronic administration of antiepileptic drugs...
Effects of standard treatment on the dynamics of matrix metalloproteinases gene expression in patients with acute coronary syndromes.
Inflammation plays a critical role in the pathology of acute coronary syndrome (ACS). Matrix metalloproteinases (MMP) - proteolytic enzymes participating in plaque destabilization - are the crucial effectors of proinflam...
Family-based study of brain-derived neurotrophic factor (BDNF) gene polymorphism in alcohol dependence.
Brain-derived neurotrophic factor (BDNF) belongs to a family of proteins related to the nerve growth factor family, which are responsible for the proliferation, survival and differentiation of neurons. BDNF is thought to...
Protective effects of histamine H(3)-receptor ligands in schizophrenic behaviors in experimental models.
Schizophrenia (SCZ) afflicts around 1% of the world's population with characteristic symptoms such as hallucinations, delusions, and cognitive disorders. Several experimental studies in the past have indicted brain hista...
Effects of GABA(B) receptor ligands in rodent tests of anxiety-like behavior.
GABAergic hypothesis of anxiety was introduced many years ago, however, a limited number of supporting data were accumulated so far and the role of GABA(B) receptors in behavioral processes related to the anxiety disorde...